T1	Participants 60 116	men treated for symptomatic benign prostatic hyperplasia
T2	Participants 373 397	men aged > or = 50 years
T3	Participants 690 702	372 patients
T4	Participants 812 913	64% of the patients reported erectile dysfunction (ED) and 63% reported ejaculatory dysfunction (EjD)
